Among substance abuse, alcohol is one of the most wildly used substances. Alcohol abuse affects 18 million people with a direct cost of $27 billion annually for alcohol-related illnesses in the United States alone. Excessive alcohol ingestion is associated with the impairment of cognitive function and even structural deterioration in the brain. The brain imaging technique has significantly contributed to our understanding of the effect of alcohol abuse and its correlation to functional and structural changes in the human brain. The assessment of brain glucose metabolism is a reliable measure of cerebral function. Studies using positron emission tomography (PET) have indicated that acute alcohol exposure results in lower brain glucose utilization, reflecting a decrease in brain activities. However, the molecular factor responsible for such neurosuppression has not yet been elucidated. In this project, we propose to test a novel concept that a newly-identified inflammatory mediator, cold-inducible RNA-binding protein (CIRP), is responsible for the reported decrease in neuronal activities in alcoholics. In our preliminary study, we have established the use of the advanced, non-invasive, and real-time microPET imaging technology to monitor brain activities in the mouse. Our results showed that alcohol intoxication in wild-type mice produced significant decrease in brain glucose metabolism. In contrast, CIRP knockout mice were more resistant to the decrease in brain glucose metabolism induced by acute alcohol exposure, suggesting CIRP may mediate central neurosuppression. In addition, CIRP protein levels increased in the hypothalamus of the brain and cerebral spinal fluid in alcohol-exposed wild-type animals. In murine microglia (brain macrophages) BV2 cells, alcohol exposure increased CIRP's mRNA and protein expression as well as its release into the extracellular matrix in a dose-dependent manner. Moreover, recombinant murine CIRP (rmCIRP) caused inflammation and tissue injury. Based on these observations, we hypothesize that alcohol intoxication increases brain CIRP expression and release, which cause the reduction of brain activities. To test this hypothesis, we will further confirm the direct role of CIRP in reducing central neuronal activities after alcohol exposure, and to determine the molecular mechanism responsible for alcohol-induced CIRP expression in the brain. These studies should provide useful information that will allow us to pinpoint the mechanism of alcohol-induced brain damage and central neurosuppression mediated by upregulation of CIRP.

Public Health Relevance

Among substance abuse, alcohol is the most wildly used substance. It is estimated that 50% of Americans 12 years or older consume alcohol at least once a month and 6.8% of them are considered as heavy drinkers. Drinking alcohol at high levels for a long term accounts for over 50,000 hospitalizations with 4% deaths. The direct cost of alcohol-related illnesses in the US has been estimated to be $27 billion annually. Our unique and innovative approach will prove the novel concept that a newly-identified inflammatory mediator called CIRP could be responsible for the reported decrease in brain activities in alcoholics. These studies will provide insights into potential therapeutic approaches in alcohol-induced central neurosuppression. 1

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21AA021496-01
Application #
8364583
Study Section
Health Services Research Review Subcommittee (AA)
Program Officer
Murray, Gary
Project Start
2012-07-01
Project End
2014-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
1
Fiscal Year
2012
Total Cost
$240,422
Indirect Cost
$96,672
Name
Feinstein Institute for Medical Research
Department
Type
DUNS #
110565913
City
Manhasset
State
NY
Country
United States
Zip Code
11030